Santen Pharmaceutical Co., Ltd.
Text Size
S
M
L
For Patients
For
Patients
EMEA
Asia
Japan
Investors
Investors
Management Policies
Financial Summary
Latest IR Documents
IR Library
Other IR Information
Stock Information
IR Contact
Corporate Governance
Partnering
Partnering
Areas of Interest
Our Partners
Contact Us
R&D
CSR
CSR
CSR at Santen
Maintenance and
Enhancement of
Trust in Products
and Services
Encouragement of
an Organizational
Culture that Promotes
Value Creation
Reinforcement of
Governance and
Prevention of
Corruption
Conservation of
the Global Environment
Contribution to
the Ophthalmology
Building Inclusive
Society
Stakeholder
Engagement
CSR Library
About Us
About Us
Greetings
CORE PRINCIPLE /
WORLD VISION
Santen 2030
Efforts to Enhance
Patients' Satisfaction
Business Activities
Quality Compliance
Corporate Governance
Overview
Measures To Combat
COVID-19 Infections
Home
Santen Global
Contact
Careers
Santen Global
Japan
Headquarters (Santen Pharmaceutical Co., Ltd.) (Japanese)
Headquarters (Santen Pharmaceutical Co., Ltd.) (English)
Asia
Singapore (Santen Pharmaceutical Asia Pte. Ltd.)
China (Santen Pharmaceutical (China) Co., Ltd.)
Korea (Santen Pharmaceutical Korea, Co., Ltd.)
Taiwan (Taiwan Santen Pharmacuetical Co., Ltd.)
North America
United States (Santen Inc.)
United States (Advanced Vision Science, Inc.)
United States (InnFocus Inc.)
Canada (Santen Canada Inc.)
EMEA (Europe, the Middle
East and Africa)
Austria
Belgium & Luxembourg
Bulgaria
Czech Republic
Denmark
Estonia
Finland (Santen Oy)
France (Santen S.A.S.)
Germany (Santen GmbH)
Hungary
Ireland
Italy (Santen Italy s.r.l.)
Latvia
The Netherlands
Norway
Poland
Portugal
Romania
Russia (SANTEN LIMITED LIABILITY COMPANY)
Slovakia
Spain (Santen Pharmaceutical Spain, S.L.)
Sweden (SantenPharma AB)
Switzerland (Santen SA)
UK (Santen UK Ltd.)
Keyword search
Home
News
2021
2021 News
Show All
Press Release
Information
Show All
Press Release
Information
01.08.2021
Information
Corporate Social Responsibility (CSR) page on our website has been updated
